News

Show
news from

Purespring strengthens senior leadership with appointment of Chief Medical Officer and Chief Development Officer

Autolus Therapeutics announces publication of obe-cel (AUTO1) Phase 1 ALLCAR19 data in adults with relapsed/ refractory B-ALL in Journal of Clinical Oncology

Syncona announces First Quarter Update

Freeline Appoints Michael J. Parini as Chief Executive Officer and Reports Second Quarter 2021 Financial Results

Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Quarter 2021 Financial Results on Monday, August 16

Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights

Load more

Search